Figure 3From: Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study Purchase of ACT within 24 hours of symptom onset at baseline, monitoring rounds (1, 2 and 3) and final survey round. Back to article page